Drug · DIN 02429659
EZETIMIBE
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since September 29, 2026; first marketed September 16, 2014.
- Drug Identification Number (DIN)
- 02429659
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ezetimibe C10AX09
- Class
- Human
- Record last updated
- October 2, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EZETIMIBE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 29, 2026: NOC 38378Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers
- January 18, 2017: NOC 18884Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
- September 15, 2014: NOC 16091Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named EZETIMIBE
- DIN 02422549 · Marketed
- DIN 02431300 · Marketed
- DIN 02478544 · Marketed